InvestorsHub Logo
Followers 21
Posts 1213
Boards Moderated 0
Alias Born 10/04/2014

Re: tmeier post# 1871

Wednesday, 12/18/2019 6:14:30 PM

Wednesday, December 18, 2019 6:14:30 PM

Post# of 3140
This is part of the PR on Dec 9th that I like, and I do believe this is what the money is going to be used for once they file NDA we are golden.

The Company currently intends to use the net proceeds from the offering for working capital and general corporate purposes, including advancing preparations for a planned New Drug Application (NDA) filing to the FDA for intravenous rigosertib in second-line higher-risk MDS in 2020.
The Company surpassed 90% of the required enrollment of the INSPIRE Trial in November 2019 and anticipates reporting topline data in the first half of 2020, following full enrollment and reaching the number of required survival events.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONTX News